Enhanced lymphodepletion is insufficient to replace exogenous IL-2 or IL-15 therapy in augmenting the efficacy of adoptively transferred effector CD8+ T cells C. Bryce Johnson, Bennett R May, Brian P Riesenberg, Samantha Suriano, Shikhar Mehrotra, Elizabeth Garret-Mayer, Mohamed L. Salem, Emily K. Jeng, Hing C. Wong, Chrystal M. Paulos, John Wrangle, David J Cole and Mark P. Rubinstein Cancer Res April 10 2018 DOI: 10.1158/0008-5472.CAN-17-2153
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile